Table 3

Multivariable analysis of factors associated with mortality in patients with type 2 diabetes and COVID-19 treated with sitagliptin or with standard-of-care therapy

OR (95% CI)P value
Treatment with sitagliptin0.23 (0.12–0.46)0.0001
Sex (male)1.05 (0.51–2.16)0.88
Age (years)1.07 (1.04–1.11)0.0001
Cancer1.74 (0.78–3.88)0.17
Cardiovascular disease2.5 (1.30–4.81)0.006
Chronic kidney disease1.12 (0.54–2.35)0.74
Use of hydroxychloroquine1.47 (0.55–3.87)0.43
Use of antiviral agents0.91 (0.44–1.85)0.79